International Total Current Liabilities from 2010 to 2024
| IBT Stock | 704.00 4.00 0.57% |
Total Current Liabilities | First Reported 2004-08-31 | Previous Quarter 34.3 M | Current Value 34.3 M | Quarterly Volatility 11.7 M |
Check International Biotechnology financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among International Biotechnology's main balance sheet or income statement drivers, such as Interest Expense of 2.3 M, Selling General Administrative of 1.1 M or Total Revenue of 21.1 M, as well as many indicators such as . International financial statements analysis is a perfect complement when working with International Biotechnology Valuation or Volatility modules.
International | Total Current Liabilities |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in International Stock
International Biotechnology financial ratios help investors to determine whether International Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in International with respect to the benefits of owning International Biotechnology security.